FreeGulliver LLC’s Eli Lilly LLY Stock Holding History

FreeGulliver LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$590K	Buy	642 +25	+4%	+$25.3K	0.25%	47
2025 Q4	$663K	Buy	617 +153	+33%	+$146K	0.24%	45
2025 Q3	$354K	Buy	+464	New	+$345K	0.16%	65
2025 Q2	–	Sell	-122	Closed	-$101K	–	92
2025 Q1	$101K	Sell	122 -185	-60%	-$154K	0.05%	93
2024 Q4	$237K	Buy	307 +47	+18%	+$38.9K	0.11%	80
2024 Q3	$230K	Buy	+260	New	+$234K	0.14%	73

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FreeGulliver LLC's LLY Position: Q1 2026 in Review

FreeGulliver LLC increased its Eli Lilly (LLY) stake by 4.1% in Q1 2026, buying an estimated $25.3K and bringing the position to 642 shares worth $590K. The position accounts for 0.25% of the portfolio, ranked #47.

FreeGulliver LLC first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $663K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

FreeGulliver LLC held 642 shares of Eli Lilly worth $590K as of Q1 2026.
FreeGulliver LLC bought 25 Eli Lilly shares in Q1 2026, an estimated $25.3K.
Eli Lilly made up 0.25% of FreeGulliver LLC's portfolio in Q1 2026, its #47 holding.
FreeGulliver LLC first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
FreeGulliver LLC's Eli Lilly position peaked at $663K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on FreeGulliver LLC's 13F filing for Q1 2026, filed 15 May 2026.